Top Markets
#1 Zora Zora +25.35%
#2 SSV Network SSV Network +24.17%
#3 Pieverse Pieverse +23.14%
#4 Fabric Protocol Fabric Protocol +22.96%
#5 Arowana Arowana +22.62%
#6 Backpack Backpack +22.55%
#7 GALA GALA +22.43%
#8 The Black Bull The Black Bull +22.09%
#9 Velvet Velvet +21.09%
#10 Derive Derive +20.55%
Coin of the day
Zora Zora
Settings
Language
ENGLISH
Currency
USD
Theme
Stablecoin Development Corp. Stablecoin Development Corp.

Stablecoin Development Corp.

SDEV
Rank in Stocks #24862
Stablecoin Development Corp. specializes in manufacturing and distributing eye... Stablecoin Development Corp. specializes in manufacturing and distributing eye and skin health solutions that have undergone rigorous scientific development and proven efficacy in clinical settings. Their product portfolio features prominent brands such as Avenova, NeutroPhase, and DERMAdoctor. This enterprise was established on January 19, 2000, and its main office is situated in Emeryville, California.
Share Price
$1.11
Last synced: 2026-08-20
Market Cap
$55.75M
Change (1 day)
8.33%
Change (1 year)
-
Country
US
Trade Stablecoin Development Corp. (SDEV)

Category

Healthcare
Revenue for Stablecoin Development Corp. (SDEV)
Revenue in Aug 2026 TTM: 0
According to Stablecoin Development Corp. latest financial reports the company's current revenue (TTM) is 0. In 2026 the company made a revenue of 0 equal to the revenue in the year 2026 that was 0. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Stablecoin Development Corp. from 2026 to 2026
Revenue at the end of each year
Year Revenue Change
Not enough data for the provided dates.
Revenue for similar companies or competitors
Company Revenue Revenue Difference Country
Royalty Pharma plc Royalty Pharma plc
Royalty Pharma plc
RPRX.US
 $2.54B -
US
Swedish Orphan Biovitrum AB Swedish Orphan Biovitrum AB
Swedish Orphan Biovitrum AB
SOBI.ST
 - -
SE
Ipsen S.A. Ipsen S.A.
Ipsen S.A.
IPN.PA
 - -
FR
Corcept Therapeutics Incorporated Corcept Therapeutics Incorporated
Corcept Therapeutics Incorporated
CORT.US
 $830.81M -
US
Sino Biopharmaceutical Limited Sino Biopharmaceutical Limited
Sino Biopharmaceutical Limited
1177.HK
 $4.55B -
HK